Periodontal Disease Treatment Market, by Type (Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease, Others), Treatment Type (Non-surgical Treatment, Surgical Treatment), Drugs (Systematic Antibiotics, Local Antibiotics), Route of Administration (Oral, Injectable), End-User (Hospitals, Dental Clinic, Dental Academics and Research Institutes, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America) and Forecast
Get Free Sample Report: https://www.delvens.com/get-free-sample/periodontal-disease-treatment-market
The Periodontal Disease Treatment market size was estimated at USD 799.17 million in 2023 and is projected to reach USD 1438.54 million in 2030 at a CAGR of 8.76% during the forecast period 2023-2030.
Periodontal disease treatment typically involves a combination of professional dental cleaning, scaling and root planning to remove plaque and tartar, as well as addressing any underlying issues. In severe cases, surgical procedures might be necessary to reduce pocket depths and promote gum tissue regeneration. Maintaining good oral hygiene and regular dental check-ups are also crucial for managing and preventing periodontal disease.
The growth of the periodontal disease treatment market can be attributed to several factors. The increasing awareness about oral health and the consequences of untreated periodontal disease is driving the demand for treatment options. Moreover, as the global population ages, the prevalence of periodontal diseases tends to increase, leading to a higher demand for the treatment. In addition, technological advancements in dental procedures, including laser therapy and minimally invasive treatments, are improving the effectiveness and patient experience of periodontal disease treatments.
The prominent players in the Periodontal Disease Treatment market are
· 3M
· Bausch Health Companies Inc.
· Biohorizons Implant Systems Inc.
· Colgate-Palmolive Company Limited
· Danaher Corporation
· Den-Mat Holdings LLC
· Dexcel Pharma
· Institut Straumann AG
· Izun Pharmaceuticals
· Kaken Pharmaceutical Co.,Ltd.
· Lyne Laboratories
· Medtronic PLC
· Mylan N.V.
· Noveome Biotherapeutics, Inc
· Pfizer Inc
· Sunstar Suisse S.A
· Tolmar Pharmaceuticals, Inc and More
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/periodontal-disease-treatment-market
Recent Developments
In April 2023, Novo Nordisk collaborated with Aspect Biosystems, a company involved in bioprinting biomaterials, for the development of bioprinted tissue therapeutics for obesity and diabetes.
In March 2022, Biocomposites signed an agreement with Zimmer Biomet to distribute the new genex Bone Graft Substitute. Genex Bone Graft Substitute is a biphasic composite of exceptional purity specifically formulated to balance osteoconductive scaffold strength and persistence in the body to enable the optimal remodeling of bone architecture.
North America to Dominate the Market
North America is estimated to account for the largest market share during the forecast period. This is because of the presence of major key players in the region and growing initiatives by the local government for the improvement of oral care.
Moreover, provision of knowledgeable dental workforce to address the high unmet needs in this region is expected to drive the market during the forecast period.
Key Findings:
Based on type, the market is segmented into gingivitis, chronic periodontal disease, aggressive periodontal disease, others. Gingivitis dominated the market in this segment. This is because gingivitis is one of the most common types of periodontitis. It is usually caused by poor oral hygiene and red, swollen gums. They also tend to bleed easily.
Based on treatment type, the market can be segmented into non-surgical treatment, surgical treatment. Non-surgical treatments dominated the market in this segment. This is because surgical procedures are not often recommended as compared to non-surgical procedures such as systematic antibiotics therapies.
Based on drugs, the market is segmented into systematic antibiotics, local antibiotics. The systematic antibiotics dominated the market in this segment. This can because systematic antibiotics are less invasive than surgery, less painful, and take less time to complete.
Based on route of administration the market is segmented into oral, injectable. The oral route dominated the market in this segment. This is because the oral route is the most common route of administration for periodontal dental treatments as drugs are administered orally in the form of tablets, capsules, or liquids.
Based on End-User, the market is segmented into hospitals, dental clinic, dental academics and research institutes, others. Dental Clinics dominated the market in this segment as for most of the dental-related problems, people prefer to consult a dentist.
Access Full Report: https://www.delvens.com/report/periodontal-disease-treatment-market
In addition to the market data for the Periodontal Disease Treatment Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
Access More Related Reports:
Immunohistochemistry (IHC) Market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
